Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacotherapy of Patients Taking New Psychoactive Substances: A Systematic Review and Analysis of Case Reports
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-23
DOI
10.3389/fpsyt.2021.669921
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review
- (2021) Fabrizio Schifano et al. EXPERIMENTAL NEUROLOGY
- Comparative neuropharmacological studies on three pyrrolidine-containing synthetic cathinones
- (2020) Jakub Wojcieszak et al. Forensic Toxicology
- NBOMes–Highly Potent and Toxic Alternatives of LSD
- (2020) Jolanta B. Zawilska et al. Frontiers in Neuroscience
- In vitro and in vivo pharmacological characterization of the synthetic opioid MT-45
- (2020) S Bilel et al. NEUROPHARMACOLOGY
- The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats
- (2020) Simon D. Brandt et al. PSYCHOPHARMACOLOGY
- Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health
- (2019) Barbara Lovrecic et al. International Journal of Environmental Research and Public Health
- Benzodiazepines Associated With Acute Respiratory Failure in Patients With Obstructive Sleep Apnea
- (2019) Sheng-Huei Wang et al. Frontiers in Pharmacology
- Current perspectives on the opioid crisis in the US healthcare system
- (2019) Nicoleta Stoicea et al. MEDICINE
- Designer Benzodiazepines: A Review of Published Data and Public Health Significance
- (2019) H. Karl Greenblatt et al. Clinical Pharmacology in Drug Development
- New/emerging psychoactive substances and associated psychopathological consequences
- (2019) F. Schifano et al. PSYCHOLOGICAL MEDICINE
- The clinical challenges of synthetic cathinones
- (2019) Fabrizio Schifano et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Synthetic cathinones: an evolving class of new psychoactive substances
- (2019) João L. Gonçalves et al. CRITICAL REVIEWS IN TOXICOLOGY
- New psychoactive substances: challenges for drug surveillance, control, and public health responses
- (2019) Amy Peacock et al. LANCET
- Intoxication with 3-MeO-PCP alone
- (2019) Antoine Berar et al. MEDICINE
- Acute severe intoxication with cyclopropylfentanyl, a novel synthetic opioid
- (2019) Maurice Wilde et al. TOXICOLOGY LETTERS
- New and Emerging Illicit Psychoactive Substances
- (2018) Ryan Graddy et al. MEDICAL CLINICS OF NORTH AMERICA
- Intoxication from the novel synthetic cannabinoids AB-PINACA and ADB-PINACA: A case series and review of the literature
- (2018) Patil Armenian et al. NEUROPHARMACOLOGY
- Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
- (2018) Patil Armenian et al. NEUROPHARMACOLOGY
- First Case in Italy of Fatal Intoxication Involving the New Opioid U-47700
- (2018) Enrico Gerace et al. Frontiers in Pharmacology
- New synthetic opioids: Part of a new addiction landscape
- (2018) Laurent Karila et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014–2017
- (2018) Joseph E. Carpenter et al. CLINICAL TOXICOLOGY
- Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?
- (2018) Jonna M. Leyrer-Jackson et al. PSYCHOPHARMACOLOGY
- A non-fatal intoxication and seven deaths involving the dissociative drug 3-MeO-PCP
- (2017) Anna Johansson et al. FORENSIC SCIENCE INTERNATIONAL
- Designer drugs: Review and implications for emergency management
- (2017) A Pourmand et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Two Cases of Non-fatal Intoxication with a Novel Street Hallucinogen: 3-Methoxy-Phencyclidine
- (2017) Monika Zidkova et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- New Psychoactive Substances in Pediatric Patients
- (2017) Brandon J. Warrick et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones
- (2017) Dino Luethi et al. TOXICOLOGY
- An Expanding World of Novel Psychoactive Substances: Opioids
- (2017) Jolanta B. Zawilska Frontiers in Psychiatry
- Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study
- (2016) Simon L. Hill et al. CLINICAL TOXICOLOGY
- Two cases of intoxication with new synthetic opioid, U-47700
- (2016) K. Domanski et al. CLINICAL TOXICOLOGY
- Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class
- (2016) Aaron Schneir et al. CLINICAL TOXICOLOGY
- The Role of Benzodiazepines in the Treatment of Epilepsy
- (2016) Juan G. Ochoa et al. Current Treatment Options in Neurology
- Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases
- (2016) Kayla N. Ellefsen et al. DRUG METABOLISM REVIEWS
- “Bath salts” intoxication: a new recreational drug that presents with a familiar toxidrome
- (2016) Christine Hall et al. Canadian Journal of Emergency Medicine
- Adverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication - A Systematic Review with Meta-Analyses of Randomised Trials
- (2015) Elisabeth I Penninga et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Pharmacological profile of novel psychoactive benzofurans
- (2015) Anna Rickli et al. BRITISH JOURNAL OF PHARMACOLOGY
- Case series: toxicity from 25B-NBOMe – a cluster of N-bomb cases
- (2015) Paul Gee et al. CLINICAL TOXICOLOGY
- A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment
- (2015) Robert J. Tait et al. CLINICAL TOXICOLOGY
- 'Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting
- (2014) C. D. Smith et al. CLINICAL MEDICINE
- Patterns of presentation and clinical features of toxicity after reported use of ([2-aminopropyl]-2,3-dihydrobenzofurans), the ‘benzofuran’ compounds. A report from the United Kingdom National Poisons Information Service
- (2014) Ashraf Kamour et al. CLINICAL TOXICOLOGY
- Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe
- (2014) M. H. Y. Tang et al. CLINICAL TOXICOLOGY
- MT-45, a new psychoactive substance associated with hearing loss and unconsciousness
- (2014) A. Helander et al. CLINICAL TOXICOLOGY
- Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
- (2014) Marisol S. Castaneto et al. DRUG AND ALCOHOL DEPENDENCE
- Fatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl)benzofuran (5-APB)
- (2014) Piotr Adamowicz et al. FORENSIC SCIENCE INTERNATIONAL
- Neonatal withdrawal syndrome after chronic maternal consumption of 4-methylethcathinone
- (2014) Simona Pichini et al. FORENSIC SCIENCE INTERNATIONAL
- Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues
- (2014) LJ Schep et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- Intravenous Administration and Abuse of Bupropion
- (2014) Kirsten Oppek et al. Journal of Addiction Medicine
- New Drugs of Abuse
- (2014) Megan A. Rech et al. PHARMACOTHERAPY
- “Not for Human Consumption”: A Review of Emerging Designer Drugs
- (2014) Megan E. Musselman et al. PHARMACOTHERAPY
- Khat and synthetic cathinones: a review
- (2013) Maria João Valente et al. ARCHIVES OF TOXICOLOGY
- “Spiceophrenia”: a systematic overview of “Spice”-related psychopathological issues and a case report
- (2013) Duccio Papanti et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Electroconvulsive Therapy Improves Persistent Psychosis After Repeated Use of Methylenedioxypyrovalerone (“Bath Salts”)
- (2013) Thomas M. Penders et al. JOURNAL OF ECT
- A Case of Cannabinoid Hyperemesis Syndrome Caused by Synthetic Cannabinoids
- (2013) Christopher Y. Hopkins et al. JOURNAL OF EMERGENCY MEDICINE
- Cristalius: A Case in Designer Drugs
- (2013) Jared Lenz et al. MILITARY MEDICINE
- Case 40-2013
- (2013) Theodore I. Benzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat
- (2013) Patrick Dawson et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Three cases of “spice” exposure
- (2011) Joshua Simmons et al. CLINICAL TOXICOLOGY
- Paranoid psychosis induced by consumption of methylenedioxypyrovalerone: two cases
- (2011) Joseph L. Antonowicz et al. GENERAL HOSPITAL PSYCHIATRY
- Hallucinatory delirium following use of MDPV: “Bath Salts”
- (2011) Thomas M. Penders et al. GENERAL HOSPITAL PSYCHIATRY
- Repeated Exposure to Methamphetamine, Cocaine or Morphine Induces Augmentation of Dopamine Release in Rat Mesocorticolimbic Slice Co-Cultures
- (2011) Takayuki Nakagawa et al. PLoS One
- “Spice” Girls: Synthetic Cannabinoid Intoxication
- (2010) Aaron B. Schneir et al. JOURNAL OF EMERGENCY MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now